July 14th, 2010, by David Pascoe | galderma, oracea, patents
A market analyst report just published speculates that Mylan Inc. may be in a position to market Generic Oracea as soon as the first quarter of 2011. These speculations are based on the successful outcome of a trial set down for December 2010 where Mylan will argue …
March 30th, 2010, by E.L. Hodge | flushing, laser therapy, patents
Today we welcome a new writer for Rosacea News – E.L. Hodge. Great to have you and we are all looking forward to hearing more of your thoughts !
How to best optimize laser and IPL treatments has long been debated. Should the rosacean deliberately engineer a flush prior to treatment? Should anti-inflammatories or anti-hypertensives be taken after treatment? Of course, many have long since reached …
November 6th, 2009, by David Pascoe | LED Therapy, patents
A newly filed patent contains a proposed rosacea treatment using small bands of infrared radiation between 790nm and 900nm with a power between 1 and 100 mW/cm^2. The unit proposed could be a LED device, used …
September 21st, 2009, by David Pascoe | galderma, oracea, patents
In a further confirmation that the low dose doxycycline market is a becoming a fighting ground, a recent press release states that Impax Laboratories has filed “Abbreviated New Drug Application ("ANDA") containing a paragraph IV certification for a generic version of ORACEA with the U.S. Food & Drug Administration ("FDA").” This is a challenge to the patents held by Galderma, relating …
August 28th, 2009, by David Pascoe | patents, sunscreens
An interesting looking patent application proposing a water based sunscreen for rosacea sufferers has surfaced at the USPTO. Many rosacea sufferers will know the trauma of finding a sunscreen that is gentle enough to not cause a bad reaction and effective enough to protect from the harm of the sun. For me the sun has always been my worst trigger. Certainly physical sunscreens …
|
|
|
|
|
|
|
|
 |